Steven Elms Joins Pernix Board

Steven Elms, a managing partner at private equity firm Aisling Capital, has joined the board of publicly traded pharmaceutical company Pernix Therapeutics Holdings Inc. Previously, Elms was a senior member of the Life Sciences Investment Banking Group of Hambrecht & Quist. Penix Therapeutics is focused on the sales, marketing and development of branded and generic drugs primarily for the pediatric market.

PeopleNorth AmericaUSBriefs